logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Radiomer Therapeutics raises pre-seed funding under Fannin Partners

May 29, 2024•over 1 year ago

Round Type

seed

HoustonTherapeuticsBiotechnologyHealth Care

Investors

Fannin Partners

Description

Radiomer Therapeutics has raised an undisclosed amount of pre-seed funding and has launched under Fannin Partners, a Houston life science leader.

Company Information

Company

Radiomer Therapeutics

Location

Houston, Texas, United States

About

Radiomer Therapeutics is a novel radiopharmaceutical and radioligand therapy platform that leverages Raptamersᵀᴹ (peptide-oligonucleotide hybrids) as a targeting moiety/vector.

Related People

3 contacts

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers